A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients

Sponsor:

National Cord Blood Program

Sponsor Study ID:

6637-01; 13-H-0116

CTO #:

101774

NCT Number:

NCT01656603

Phase:

II

Protocol Type:

Treatment

Age Group:

Adults

Disease Sites:

Hodgkin's Lymphoma; Lymphoid Leukemia; Multiple Myeloma; Myeloid and Monocytic Leukemia; Non-Hodgkin's Lymphoma; Other Hematopoietic

Study Objectives:

The primary aim of this study is to examine the safety of administration of the unlicensed investigational NCBP HPC-CORD BLOOD products in a multi-institution setting. Therefore, the study will evaluate prospectively the incidence of serious adverse reactions as well as the incidence of all infusion related reactions after administration of the unlicensed, investigational NCBP CBU.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)